Kaletra (Lopinavir 200 mg / Ritonavir 50 mg)

Kaletra is an antiretroviral medicine used to treat HIV infection. It contains two active ingredients: lopinavir (200 mg) and ritonavir (50 mg). In most people, ritonavir works largely as a “booster” to help lopinavir stay in the body at effective levels.

This page provides patient-friendly information about how Kaletra works, how it is used, common interactions, and practical tips for safe use in the United Kingdom.

Key product information

How Kaletra works (mechanism of action)

HIV needs an enzyme called protease to build new, infectious virus particles. Lopinavir blocks this HIV protease. When protease is inhibited, newly produced HIV particles are less able to mature and infect new cells.

Ritonavir is included to boost lopinavir. It slows the breakdown of lopinavir in the liver, leading to higher and more reliable levels of lopinavir in the blood, which improves the effectiveness of treatment.

Pharmacokinetics (how the body handles it)

After taking Kaletra, lopinavir and ritonavir are absorbed from the gut. Ritonavir inhibits certain liver enzymes, particularly CYP3A, which reduces metabolism of lopinavir and increases its exposure.

• Metabolism: Primarily via liver enzymes, with ritonavir acting as a strong inhibitor of CYP3A.
• Elimination: Mainly through metabolism, then excretion of breakdown products.
• Steady levels: Usually build up over days with consistent dosing.
• Variability: Blood levels can vary between people due to other medicines, liver function, and adherence.

What Kaletra is used for (indications)

Kaletra is used to treat HIV-1 infection in adults and children, as part of combination antiretroviral therapy. The exact regimen depends on prior treatment history, viral resistance, and other health factors.

It is not effective against viral infections such as influenza or hepatitis C by itself, and it does not cure HIV. When taken as part of the correct regimen, it helps control HIV and can reduce the risk of complications.

Typical timing and how to take Kaletra

Dosing schedules are individualised, but many regimens use two doses per day to maintain steady drug levels. Consistency is important for maintaining viral suppression.

General timing tips

• Take at the same times each day to maintain consistent levels.
• Follow the instructions for your tablet or liquid form (they can differ in how they’re taken).
• Do not skip or stop without advice. Stopping suddenly or missing doses can lead to viral rebound and resistance.

If you miss a dose

If you miss a dose, take it when you remember unless it is near the time of the next dose. Do not take double the dose to make up for a missed one. If you are unsure, contact your healthcare team or pharmacist for personalised advice.

Dosing: common adult regimens

Dosing depends on the form (tablet vs oral solution), age, body weight (in children), liver function, and whether you are switching from another regimen. Below are commonly used adult dosing patterns. Always follow the dosing plan provided for you.

Common dosing patterns (adults)

• Twice daily regimens: often 400/100 mg (lopinavir/ritonavir) twice daily, which corresponds to two tablets of Kaletra 200/50 mg per dose.
• Once daily regimens: some people may use once-daily dosing with specific product strengths and partner regimens. Your clinician will determine the most appropriate schedule.

Important: Dose adjustments may be needed in specific circumstances, including certain drug interactions or liver impairment.

Children

In children, dosing is often calculated based on body surface area or body weight and may use tablets or oral solution. The correct approach is specific to age and weight and should be confirmed by the treatment team.

Food interactions: taking Kaletra with meals

Food can affect how much drug is absorbed. As a general principle for Kaletra:

• Many regimens advise taking Kaletra with food to improve absorption—especially the oral solution.
• Try to keep your routine consistent: taking each dose with a similar meal pattern can help maintain steady drug levels.
• If you have digestive side effects (such as nausea or diarrhoea), discuss options with your healthcare team rather than changing doses on your own.

If you are unsure whether your specific formulation should be taken with meals, check the product instructions or ask your pharmacist.

Alcohol interactions

Alcohol may increase side effects and can affect the liver. Kaletra contains ritonavir, and protease inhibitors can also influence liver metabolism. Using alcohol may increase the risk of liver-related complications in some people.

Practical guidance

• Consider limiting alcohol and avoid heavy drinking, especially if you have existing liver disease.
• Watch for symptoms such as unusual fatigue, loss of appetite, dark urine, or yellowing of the skin/eyes.
• If you drink alcohol regularly, ask your healthcare team for advice tailored to your liver function and other medicines.

Medicine interactions (very important)

Kaletra has significant interactions because ritonavir strongly affects liver enzymes (notably CYP3A) and transporters. Many medicines can become either less effective or more likely to cause side effects when used together with Kaletra.

Some combinations are not recommended because they may be unsafe or may reduce HIV control. Always keep an up-to-date list of your medicines and ask a pharmacist to check interactions before starting anything new (including over-the-counter products and herbal supplements).

Examples of medicines that commonly interact

This is not a complete list. Your pharmacist can screen for interactions based on your exact regimen.

• Anti-arrhythmics (heart rhythm medicines) may require avoidance or careful monitoring.
• Statins (cholesterol medicines) may need switching to a safer option and dose adjustment.
• Anticonvulsants (certain seizure medicines) can change lopinavir levels.
• Anticoagulants (blood thinners) may require monitoring and dose changes.
• Hormonal contraceptives: effectiveness may be affected in some situations; additional contraception may be needed.
• Acid-reducing medicines (such as proton pump inhibitors) may affect absorption depending on timing.
• Herbal products such as St John’s wort can reduce effectiveness and should generally be avoided.

What to do if you need a new medicine

• Tell the prescriber/pharmacist you take Kaletra.
• Ask specifically whether the new medicine is safe with lopinavir/ritonavir.
• Do not start or stop medicines without checking interactions.

Safety profile: what to expect and when to seek help

Like all medicines, Kaletra can cause side effects. Many are mild and improve over time, but some require prompt medical attention. Your clinician may perform blood tests to monitor liver function and other parameters.

Common side effects

• Diarrhoea, nausea, abdominal discomfort
• Headache
• Fatigue or feeling generally unwell
• Rash
• Changes in blood fats (cholesterol and triglycerides)

Important risks to be aware of

• Liver problems: Protease inhibitors can affect the liver. Tell your healthcare team if you have liver disease or develop symptoms such as yellowing of the skin/eyes or dark urine.
• Heart rhythm effects: Some drug interactions can increase risk for rhythm abnormalities. Avoid interacting medicines where instructed.
• Changes in body fat: Over time, some people may develop changes such as fat redistribution (which can be difficult to reverse).
• Diabetes or increased blood sugar: Some people develop elevated glucose. Monitoring may be needed.
• Pancreatitis (rare): Seek urgent care if you get severe abdominal pain, with or without vomiting.

Seek urgent medical help if

• Severe allergic reaction symptoms (swelling of face/lips, difficulty breathing)
• Signs of severe liver injury (yellow skin/eyes, severe right-sided upper abdominal pain)
• Fainting, severe dizziness, or palpitations with chest discomfort
• Severe persistent vomiting or inability to keep fluids down

Practical use tips for best results

Successful HIV treatment depends on adherence and avoiding interactions. These practical tips can help you get the most from your regimen.

Adherence and routine

• Use a daily reminder (phone alarm, pill organiser, or adherence app).
• If you travel, plan for extra tablets/liquid and keep them in your carry-on where appropriate.
• Keep a written list of your HIV medicines and timings.

Manage stomach side effects

• Taking doses with food (as recommended for your formulation) may help gastrointestinal tolerance.
• Stay hydrated if you experience diarrhoea.
• Do not add new anti-diarrhoea or anti-nausea medicines without checking interactions.

Monitor important labs

• Liver function tests may be monitored.
• Lipids (cholesterol/triglycerides) may need regular checks.
• Some people need monitoring for blood sugar and blood counts depending on their overall health.

Pregnancy and fertility considerations

If you are pregnant, trying to conceive, or breastfeeding, talk to your healthcare team promptly. HIV treatment choices during pregnancy are tailored to reduce risk to both parent and baby, and to consider interactions with other medicines.

Alternative options

There are multiple antiretroviral options available in the UK, and the best choice depends on resistance testing, prior treatment history, co-morbidities, and potential drug–drug interactions.

Common alternative classes

• NRTIs (nucleoside reverse transcriptase inhibitors): often form the backbone of combination therapy.
• NNRTIs (non-nucleoside reverse transcriptase inhibitors): different mechanism, sometimes simpler dosing.
• Other protease inhibitors: may be used in specific cases depending on resistance and tolerability.
• Integrase inhibitors: frequently used in modern regimens due to efficacy and tolerability.

If Kaletra is not suitable due to side effects, interactions, or other factors, your healthcare team may consider switching to a different regimen. Do not change HIV medicines without professional guidance.

Market and legal context in the United Kingdom

In the UK, medicines such as Kaletra are regulated and supplied through licensed channels. Kaletra is part of standard HIV care and is used under clinical supervision as part of combination antiretroviral therapy.

• Regulatory status: Medicines are authorised and monitored under UK medicines regulation.
• Clinical governance: HIV treatment is guided by national and specialist clinical standards, including resistance considerations and interaction checks.
• Monitoring: Routine blood tests help manage safety and long-term effects such as lipid changes and liver function.

Availability in pharmacies can depend on local supply arrangements and formulation (tablets vs oral solution). Online pharmacy availability may vary, and some products may be supplied via established fulfilment networks.

Recent guidance and clinical practice (UK overview)

HIV treatment guidance in the UK is continually updated to reflect new evidence and improved regimens. While Kaletra is an established protease inhibitor option, current practice often favours regimens with strong effectiveness, a high barrier to resistance, and convenient dosing—especially in people starting therapy.

Kaletra may still be used when it fits best due to prior resistance patterns, interaction profiles, or individual treatment history. Clinicians also consider:

• Potential drug–drug interactions with comedications (for example cholesterol medicines, heart medicines, seizure medicines)
• Metabolic effects (lipids, glucose)
• Liver health and viral hepatitis co-infection status
• Adherence support and tolerability

Always follow the most current advice from specialist HIV services and your healthcare team.

Delivery and availability (UK)

Online pharmacies in the UK may carry Kaletra in different formulations depending on stock levels and supplier networks. Delivery times can vary based on location, formulation availability, and dispatch schedules.

What to expect when ordering

• Stock status: Products may be in stock or may require sourcing from suppliers.
• Packaging: Medicines are typically supplied in the original manufacturer packaging with printed batch and expiry information.
• Identification: Some services may require verification steps to comply with safety and legal requirements.

If you need a specific formulation (tablets vs oral solution) or dose schedule, check availability before ordering.

Frequently asked questions (FAQ)

1) Can Kaletra control HIV infection but not cure it?

Yes. Kaletra helps suppress HIV so the virus becomes less detectable and the immune system can function better, but it does not cure HIV. Long-term treatment is usually needed.

2) Why is ritonavir included if lopinavir is the main drug?

Ritonavir boosts lopinavir by slowing its breakdown in the liver, increasing lopinavir exposure and improving effectiveness.

3) Should I take Kaletra with food?

In many cases, taking Kaletra with food is recommended to improve absorption and tolerability. Follow the specific instructions for your formulation. If you are unsure, ask your pharmacist.

4) Are there medicines or supplements I should avoid?

Many medicines interact with Kaletra, and some combinations can be unsafe. Herbal products like St John’s wort are particularly important to avoid. Always check with a pharmacist before starting anything new.

5) Can I drink alcohol while taking Kaletra?

It is best to limit alcohol. Alcohol can worsen side effects and may affect the liver. If you have liver disease, discuss alcohol use with your healthcare team.

6) What side effects are most common?

Gastrointestinal effects (such as diarrhoea and nausea) and headache are commonly reported. Fat and cholesterol changes may also occur, and liver-related issues are monitored in people at risk.

7) What should I do if I get diarrhoea?

Mild diarrhoea can settle, but persistent diarrhoea should be discussed. Stay hydrated and seek advice if symptoms are severe, last more than a short period, or come with fever or severe abdominal pain.

8) Will Kaletra affect cholesterol or blood sugar?

It can. Protease inhibitors may increase cholesterol and triglycerides and, in some people, contribute to changes in blood sugar. Monitoring is commonly recommended.

9) Can I stop Kaletra if my viral load is undetectable?

Do not stop HIV medicines without medical advice. Maintaining viral suppression usually requires ongoing combination therapy.

10) How long does it take to work?

HIV viral load can begin to drop within weeks, but the exact timeline varies between people. Your clinician will monitor response with blood tests.

Important safety note: Information on this page is general and cannot replace individual advice from your healthcare professional. Because Kaletra interacts with many medicines, always confirm suitability with a pharmacist—especially if you have other health conditions or take multiple medicines.